Nathalie Vanlaer has a background in clinical (neuro)psychology and currently does a PhD in medical sciences. Her doctoral research focuses on psychosocial issues, cognitive functioning and health-related quality of life in advanced cancer survivors treated with immune checkpoint blockade, and the efficacy of neurocognitive remediation therapy for cancer survivors.
Nathalie Vanlaer has a background in clinical (neuro)psychology and currently does a PhD in medical sciences. Her doctoral research focuses on psychosocial issues, cognitive functioning and health-related quality of life in advanced cancer survivors treated with immune checkpoint blockade, and the efficacy of neurocognitive remediation therapy for cancer survivors.